The mortality rate due to pancreas malignant neoplasms in the U.S. has been increasing steadily from 50.63 thousand in 2024 to a forecasted 54.3 thousand in 2028. This continuous rise indicates a year-on-year increase, with each year showing approximately a 1.75% growth in mortality rates. This trend reflects an ongoing challenge in combating pancreatic cancer.
Looking forward, key trends to watch include advances in early detection and treatment methods, which may alter these projections. Additionally, shifts in lifestyle factors, healthcare policies, and innovations in cancer research could impact future mortality rates. Monitoring these areas will be crucial to understanding and potentially reversing the increase in mortality.
